Clinicopathologic significance of expression of nuclear factor-&kappa;B RelA and its target gene products in gastric cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

299

HTML

2619

Figures (1-2)

123

Tables (1-4)

125

Sum=3166

Sep 14, 2012 (publication date) through Apr 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 14, 2012; 18(34): 4744-4750
Published online Sep 14, 2012. doi: 10.3748/wjg.v18.i34.4744

Full Size Figure Download Figure

Figure 2 Overall survival curve. A: Serum amyloid A (SAA) expression (P < 0.001); B: Nuclear factor-κB (NF-κB) expression (P < 0.001).

Citation: Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Jang JS, Kim MC, Kim KH, Kim SJ, Kim SG, Kim HJ. Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients. World J Gastroenterol 2012; 18(34): 4744-4750
URL: https://www.wjgnet.com/1007-9327/full/v18/i34/4744.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i34.4744